1. Home
  2. RCUS vs CXT Comparison

RCUS vs CXT Comparison

Compare RCUS & CXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$22.78

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Crane NXT Co.

CXT

Crane NXT Co.

HOLD

Current Price

$48.03

Market Cap

3.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCUS
CXT
Founded
2015
1855
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.0B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
RCUS
CXT
Price
$22.78
$48.03
Analyst Decision
Buy
Buy
Analyst Count
8
4
Target Price
$29.38
$76.75
AVG Volume (30 Days)
2.3M
674.1K
Earning Date
10-28-2025
02-11-2026
Dividend Yield
N/A
1.42%
EPS Growth
N/A
N/A
EPS
N/A
2.68
Revenue
$240,000,000.00
$1,578,900,000.00
Revenue This Year
N/A
$10.77
Revenue Next Year
N/A
$6.74
P/E Ratio
N/A
$17.91
Revenue Growth
N/A
9.30
52 Week Low
$6.50
$41.54
52 Week High
$26.40
$69.00

Technical Indicators

Market Signals
Indicator
RCUS
CXT
Relative Strength Index (RSI) 50.10 27.36
Support Level $21.80 $46.02
Resistance Level $22.70 $48.75
Average True Range (ATR) 1.27 1.85
MACD -0.45 -0.52
Stochastic Oscillator 38.18 15.02

Price Performance

Historical Comparison
RCUS
CXT

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About CXT Crane NXT Co.

Crane NXT Co is a industrial technology company that provides proprietary and trusted technology solutions to secure, detect, and authenticate what matters to its customers. It is a pioneer in proprietary micro-optics technology for securing physical products, and its sophisticated electronic equipment and associated software leverages proprietary core capabilities with detection and sensing technologies. The company operates in two segments which are Crane Payment Innovations (CPI) and Security and Authentication Technologies.

Share on Social Networks: